Updated data disclosed from RADIANT-2 and -3 trials of everolimus in neuroendocrine tumors Feb. 2, 2011
First-line TH-302 plus gemcitabine shows promise in advanced/metastatic pancreatic cancer Feb. 1, 2011
Phase II data presented on sorafenib in GIST and esophageal/gastroesophageal junction cancer Feb. 1, 2011
Lapatinib plus capecitabine does not improve survival of patients with metastatic pancreatic cancer Jan. 31, 2011
RSS